Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma
Glioblastoma is an incurable cancer with a 5-year survival chance of less than 5%. Chemotherapy is a therapeutic approach to treating the disease; however, due to the presence of the blood-brain barrier (BBB), the probability of success is low. To overcome this issue, nanoparticles are promising car...
Saved in:
Main Authors: | Mohsen Ghaferi (Author), Aun Raza (Author), Maedeh Koohi (Author), Warda Zahra (Author), Azim Akbarzadeh (Author), Hasan Ebrahimi Shahmabadi (Author), Seyed Ebrahim Alavi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics
by: Seyed Ebrahim Alavi, et al.
Published: (2022) -
Preparation, Characterization, and Evaluation of Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved In Vitro and In Vivo Anticancer Activities
by: Mohsen Ghaferi, et al.
Published: (2020) -
Pegylated liposomal doxorubicin in ovarian cancer
by: Robert Strother, et al.
Published: (2009) -
Pegylated liposomal doxorubicin in the management of ovarian cancer
by: Gabriella Ferrandina, et al.
Published: (2010) -
Pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia
by: Joana Moreira-Barros, et al.
Published: (2018)